Antithymocyte immunoglobulin (rabbit)

Generic Name
Antithymocyte immunoglobulin (rabbit)
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
308067-60-9
Unique Ingredient Identifier
D7RD81HE4W
Background

Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells.

Indication

For prevention of renal transplant rejection

Associated Conditions
Rejection Acute Renal
Associated Therapies
-

Autologous Transplant To End NMO Spectrum Disorder

First Posted Date
2019-02-04
Last Posted Date
2019-11-20
Lead Sponsor
Northwestern University
Registration Number
NCT03829566
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

First Posted Date
2019-01-28
Last Posted Date
2019-02-01
Lead Sponsor
Hospital Israelita Albert Einstein
Target Recruit Count
50
Registration Number
NCT03818334
Locations
🇧🇷

Hospita Israelita Albert Eintein, São Paulo, SP, Brazil

Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

First Posted Date
2018-12-28
Last Posted Date
2019-01-03
Lead Sponsor
University of Khartoum
Target Recruit Count
300
Registration Number
NCT03789006
Locations
🇸🇩

Doctor Salma Center for Kidney Diseases, Khartoum, Sudan

PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

First Posted Date
2018-09-28
Last Posted Date
2019-10-28
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
260
Registration Number
NCT03689465
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

🇨🇳

Xiangya Hospital, Central South University, Changsha, Hunan, China

🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

and more 4 locations

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

First Posted Date
2018-07-26
Last Posted Date
2022-04-12
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
3
Registration Number
NCT03600909
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

First Posted Date
2018-07-24
Last Posted Date
2024-06-12
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
4
Registration Number
NCT03597594
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Cardiac Safe Transplants for Systemic Sclerosis

First Posted Date
2018-07-20
Last Posted Date
2020-08-12
Lead Sponsor
Northwestern University
Target Recruit Count
9
Registration Number
NCT03593902
Locations
🇺🇸

Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

Phase 2
Conditions
Interventions
First Posted Date
2018-01-10
Last Posted Date
2019-04-16
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Target Recruit Count
100
Registration Number
NCT03395860
Locations
🇨🇳

Shanghai First People's HOSPITAL, Shanghai, Shanghai, China

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

First Posted Date
2018-01-02
Last Posted Date
2022-11-25
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
27
Registration Number
NCT03388008
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Maximizing Outcome of Multiple Sclerosis Transplantation

First Posted Date
2017-11-17
Last Posted Date
2021-01-11
Lead Sponsor
Northwestern University
Target Recruit Count
66
Registration Number
NCT03342638
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath